GCC
CVS icon

Guardian Capital (Canada)’s CVS Health CVS Stock Holding History

Guardian Capital (Canada)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,100
Closed -$707K – 151
2020
Q3 		$707K Sell
12,100
-16,050
-57% -$999K 0.02% 134
2020
Q2 		$1.83M Buy
28,150
+7,350
+35% +$463K 0.05% 85
2020
Q1 		$1.23M Buy
20,800
+2,300
+12% +$154K 0.04% 91
2019
Q4 		$1.37M Buy
18,500
+3,600
+24% +$253K 0.03% 100
2019
Q3 		$940K Sell
14,900
-68
-0.5% -$4.03K 0.02% 109
2019
Q2 		$816K Buy
14,968
+4,400
+42% +$237K 0.02% 115
2019
Q1 		$570K Buy
10,568
+2,038
+24% +$126K 0.01% 126
2018
Q4 		$559K Buy
8,530
+3,450
+68% +$258K 0.01% 117
2018
Q3 		$400K Buy
+5,080
New +$363K 0.01% 153
2017
Q4 		– Sell
-4,841
Closed -$394K – 191
2017
Q3 		$394K Sell
4,841
-90,199
-95% -$7.13M 0.01% 173
2017
Q2 		$7.65M Sell
95,040
-1,836
-2% -$145K 0.12% 101
2017
Q1 		$7.61M Buy
96,876
+91,506
+1,704% +$7.31M 0.12% 101
2016
Q4 		$424K Buy
5,370
+154
+3% +$12.5K 0.01% 173
2016
Q3 		$464K Buy
5,216
+198
+4% +$18.7K 0.01% 149
2016
Q2 		$480K Sell
5,018
-3,173
-39% -$316K 0.01% 146
2016
Q1 		$850K Sell
8,191
-727
-8% -$70.7K 0.01% 132
2015
Q4 		$872K Buy
8,918
+32
+0.4% +$3.13K 0.02% 136
2015
Q3 		$857K Sell
8,886
-1,838
-17% -$193K 0.02% 138
2015
Q2 		$1.13M Sell
10,724
-435
-4% -$44.4K 0.02% 141
2015
Q1 		$1.15M Sell
11,159
-4,121
-27% -$417K 0.02% 140
2014
Q4 		$1.47M Sell
15,280
-5,818
-28% -$513K 0.02% 119
2014
Q3 		$1.68M Buy
21,098
+10,885
+107% +$858K 0.03% 123
2014
Q2 		$770K Sell
10,213
-13,895
-58% -$1.05M 0.01% 143
2014
Q1 		$1.8M Buy
24,108
+12,852
+114% +$908K 0.03% 118
2013
Q4 		$806K Sell
11,256
-11,324
-50% -$728K 0.01% 133
2013
Q3 		$1.28M Sell
22,580
-352
-2% -$21K 0.02% 131
2013
Q2 		$1.31M Buy
+22,932
New +$1.33M 0.02% 121

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Guardian Capital (Canada)'s CVS Position: Q4 2020 in Review

Guardian Capital (Canada) sold out of CVS Health (CVS) in Q4 2020, closing a stake of 12,100 shares — an estimated $707K sold.

Guardian Capital (Canada) first reported a position in CVS in Q2 2013 and held it in 27 quarters. The position peaked at $7.65M in Q2 2017. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Guardian Capital (Canada) reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
  • Guardian Capital (Canada) sold 12,100 CVS Health shares in Q4 2020, an estimated $707K.
  • Guardian Capital (Canada) first reported a position in CVS Health in Q2 2013 and held it in 27 quarters.
  • Guardian Capital (Canada)'s CVS Health position peaked at $7.65M in Q2 2017.
  • 1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Guardian Capital (Canada)'s 13F filing for Q4 2020, filed 12 Feb 2021.